Тус стартап нь эмнэлгийн цахим бүртгэлд дүн шинжилгээ хийж, эрсдэлтэй өвчтөнүүдийг эрт илрүүлэх технологийг хөгжүүлж байна
Эмнэлгийн өвчтөний түүх болон эмч нарын тэмдэглэлд дүн шинжилгээ хийж, оношлогдоогүй өвчний эрсдэлийг тодорхойлдог Healthleap стартап 38 сая долларын хөрөнгө оруулалт татлаа. Уг санхүүжилтийн 8 сая долларыг Sequoia Capital болон First Round Capital тэргүүлсэн бол 30 сая долларын Series A шатны хөрөнгө оруулалтыг Hummingbird Ventures удирдан зохион байгуулжээ.
2022 онд Өмнөд Африкт Жэмима болон Жосиа Мейер нарын үүсгэн байгуулсан тус компани нь эхлээд хоол тэжээлийн мэргэжилтнүүдэд зориулсан хэрэгсэл санал болгож байсан бол одоо эмнэлгийн бүх төрлийн өвчтөнийг хянах ерөнхий зориулалтын платформ болгон өргөжүүлжээ. Уг технологи нь эмнэлгийн цахим бүртгэлд хадгалагдсан лабораторийн шинжилгээ, амин үзүүлэлт зэрэг бүтцийн өгөгдлийг эмч нарын бичсэн тэмдэглэлтэй хослуулан хэлний загвар ашиглан боловсруулдаг.
Одоогоор Healthleap платформыг дэлхийн 50 гаруй эмнэлэгт ашиглаж байгаа бөгөөд хоол тэжээлийн дутагдал, солиорол зэрэг эмгэгийг эрт илрүүлэхэд голчлон ашиглаж байна. Мөн аспирацийн уушгины хатгалгаа, даралтын шарх болон зүрхний дутагдлын улмаас дахин эмнэлэгт хэвтэх эрсдэлийг тодорхойлох хөтөлбөрүүдийг клиник туршилтаар хянаж байна.
Компанийн гүйцэтгэх захирал Жосиа Мейерийн мэдээлснээр, тус систем нь өвчтөнийг шууд оношлохгүй, харин эмнэлгийн багт илүү анхаарал хандуулах шаардлагатай өвчтөнүүдийн эрсдэлийн оноог өдөр бүр гаргаж өгдөг. Шинээр татсан хөрөнгийг бүтээгдэхүүн хөгжүүлэлт, борлуулалт болон хэрэглэгчийн үйлчилгээг сайжруулахад зарцуулж, ирээдүйд 40 гаруй төрлийн өвчнийг илрүүлэх боломжтой болгохоор төлөвлөж байна.
Дэлгэрэнгүйг эх сурвалжаас харах
↓Эх сурвалжийг нээх ↓
Healthleap, a startup building an AI platform that reads patient records to identify patients at risk of undiagnosed illnesses, has raised $38 million in seed and Series A funding, TechCrunch has exclusively learned.
The financing includes an $8 million seed round co-led by Sequoia Capital and First Round Capital, and a $30 million Series A led by Hummingbird Ventures. The company is not disclosing its valuation.
Founded in South Africa in 2022 by siblings Jemima and Josiah Meyer (pictured above), the startup initially offered a clinical nutrition tool Jemima had built for dietitians. But the company later pivoted and built a more general-purpose platform that aims to identify patients admitted to hospitals who may be suffering from conditions like malnutrition or delirium that aren’t often identified early enough, CEO and co-founder Josiah Meyer told TechCrunch.
“A patient’s chart holds two kinds of data. Labs, weights, and vital signs sit in structured fields, but the most telling signs sit in clinicians’ written notes: poor appetite, recent weight loss, muscle loss, trouble swallowing. Our developing approach is extracting affirmative or negated mentions of these clinical concepts in an easily extensible and scalable way,” Josiah said.
The company’s platform is currently deployed in more than 50 hospitals, where it screens patients for conditions such as malnutrition and delirium, he said. The startup has also built programs to identify aspiration pneumonia, pressure ulcers, and risk of readmission for congestive heart failure, which Josiah said are undergoing further clinical validation.
To find patients that may be at risk of an illness or were undiagnosed, Healthleap plugs into a hospital’s electronic health record system and uses language models to pull information from written notes, such as references to recent weight loss or difficulty swallowing. That analysis is then fed into its risk models, alongside structured information such as lab reports and vitals to surface patients who may need a closer look. The company notes that its software doesn’t diagnose patients, only highlights items for additional review.
“Each night, we analyze every adult inpatient’s record: lab results, vital signs, weights, medications, diet orders, diagnoses, clinicians’ notes, and more,” Josiah explained. “Each morning, we write a risk score into the care team’s existing workflow with a dashboard accessible that holds additional information about the patients’ trends.”
Malnutrition likely served as a useful starting point for Healthleap, as it’s a condition that often goes undiagnosed and can adversely impact patient recovery in a variety of ways. Research suggests 20% to 50% of hospital inpatients are malnourished, and some studies have linked malnutrition with longer stays, impaired wound healing, infections, and other complications, as well as higher morbidity and mortality.
Josiah said Healthleap has grown from three hospital partners to more than 50 over the past year, and its customers now include Penn Medicine, Cedars-Sinai, Intermountain, Houston Methodist, and Emory Healthcare. Revenue has grown more than 10x over the same period, he said, though he didn’t disclose specifics.
The startup sells three-year contracts priced according to a hospital’s licensed bed count, and also uses an outcome-based pricing model. “We use the hard ROI that the hospital finance team validates and attributes to us as the measurable ROI. Based on that, we contractually ensure that we deliver multiples of the contract price. To date, every customer has seen a 5x hard ROI or more, in some cases over 20x annual total ROI,” Josiah said.
At the Hospital of the University of Pennsylvania, Healthleap says its malnutrition program resulted in $23.8 million in annualized financial impact, of which $6.3 million came from additional reimbursement and $17.5 million from shorter hospital stays.
Healthleap plans to spend the fresh cash on engineering, product, sales, and customer success as it adds support for identifying more conditions. Meyer said the company ultimately wants to cover more than 40 major health conditions and expand into outpatient and home care.
When you purchase through links in our articles, we may earn a small commission. This doesn’t affect our editorial independence.
